B2M expression in the plasma in the NPDR+DKD group (1.538 ± 0.691 μg/ml) was significantly upregulated compared with that in the NPDR group (1.096 ± 0.441 μg/ml) (p<0.001) (Figure 7A). The gene discussed is B2M; the disease is diabetic kidney disease.